108. TNF receptor-associated periodic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 44
TNF receptor-associated periodic syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
108 | TNF receptor-associated periodic syndrome |
267 | Hyper-IgD syndrome |
13 | Multiple sclerosis/Neuromyelitis optica |
34 | Neurofibromatosis |
46 | Malignant rheumatoid arthritis |
51 | Scleroderma |
84 | Sarcoidosis |
85 | Idiopathic interstitial pneumonia |
222 | Primary nephrotic syndrome |
228 | Bronchiolitis obliterans |
113 | Muscular dystrophy |
50 | Dermatomyositis |
56 | Behcet disease |
107 | Juvenile idiopathic arthritis |
58 | Hypertrophic cardiomyopathy |
164 | Oculocutaneous albinism |
41 | Giant cell arteritis |
269 | Pyogenic arthritis |
106 | Cryopyrin-associated periodic syndrome |
266 | Familial mediterranean fever |